Gallic Acid Inhibits Proliferation and Induces Apoptosis in Lymphoblastic Leukemia Cell Line (C121)
Leukemia is known as the world’s fifth most prevalent cancer. New cytotoxic drugs have created considerable progress in the treatment, but side effects are still the important cause of mortality.
Zahra Sourani+4 more
doaj
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma with severe eosinophilia, in a young adult patient
Introduction: Acute lymphoblastic leukemia (ALL) of B cells, is the most common subtype of ALL in children.(1,2) ALL that presents as hypereosinophilia in peripheral blood, is very rare and the incidence is <1%.(3) Case Report: In this case, is presented a girl, 25 year old girl, initially diagnosed as community acquired pneumonia and leukemoid ...
Tello-Vera, Stalin, Novoa-Pérez, Karla
openaire +1 more source
The Flow Cytometric Evaluation of B- and T-Lymphoblastic Leukemia/Lymphoma. [PDF]
Dorfman DM.
europepmc +1 more source
Diagnostic approach to leukemia cutis : A differential diagnostic step-by-step algorithm. [PDF]
Jenei A, Tzankov A.
europepmc +1 more source
Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature review. [PDF]
Yahia AE+7 more
europepmc +1 more source
Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study. [PDF]
Ushida E+12 more
europepmc +1 more source
Co-occurrence of thymoma and acute T-lymphoblastic leukemia/lymphoma: a case report and literature review. [PDF]
Frazzette N+5 more
europepmc +1 more source
Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators. [PDF]
Tóth K, Gaál Z.
europepmc +1 more source
An 8-year-old girl with secondary histiocytic sarcoma with BRAF<sup>V600</sup> mutation following T-cell acute lymphoblastic leukemia demonstrating stable disease for 3 years on dabrafenib and trametinib - a case report and literature review. [PDF]
Tan SL, Ho BLS, Yew TT, Yunus D.
europepmc +1 more source